EUR 5.83
(0.34%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.00 EUR | 100.0% |
2022 | -469 Thousand EUR | 0.0% |
2021 | - EUR | -100.0% |
2020 | 1.00 EUR | -100.0% |
2019 | 3.2 Million EUR | 220.96% |
2018 | 997 Thousand EUR | 0.0% |
2017 | - EUR | 0.0% |
2016 | - EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 Q2 | -489 Thousand EUR | 0.0% |
2023 Q3 | 1.00 EUR | 100.0% |
2023 Q1 | - EUR | 100.0% |
2023 FY | 1.00 EUR | 100.0% |
2023 Q4 | 1.00 EUR | 0.0% |
2022 Q1 | - EUR | -100.0% |
2022 Q2 | 2.26 Million EUR | 0.0% |
2022 Q3 | - EUR | -100.0% |
2022 FY | -469 Thousand EUR | 0.0% |
2022 Q4 | -469 Thousand EUR | 0.0% |
2021 Q1 | 1.00 EUR | 0.0% |
2021 FY | - EUR | -100.0% |
2021 Q4 | 295 Thousand EUR | 0.0% |
2021 Q3 | - EUR | -100.0% |
2021 Q2 | 2.13 Million EUR | 213299900.0% |
2020 Q4 | 1.00 EUR | 0.0% |
2020 Q3 | 1.00 EUR | -100.0% |
2020 Q1 | 1.00 EUR | 0.0% |
2020 FY | 1.00 EUR | -100.0% |
2020 Q2 | 2.22 Million EUR | 222799900.0% |
2019 Q3 | - EUR | 0.0% |
2019 Q4 | - EUR | 0.0% |
2019 FY | 3.2 Million EUR | 220.96% |
2019 Q1 | - EUR | 0.0% |
2018 FY | 997 Thousand EUR | 0.0% |
2017 FY | - EUR | 0.0% |
2016 FY | - EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Nicox S.A. | - EUR | -Infinity% |
European Medical Solutions | 14.35 Million EUR | 100.0% |
FERMENTALG | 6.8 Million EUR | 100.0% |
argenx SE | 281.12 Million EUR | 100.0% |
BioSenic S.A. | - EUR | -Infinity% |
Celyad Oncology SA | 1.26 Million EUR | 100.0% |
Onward Medical N.V. | 936 Thousand EUR | 100.0% |
Oxurion NV | 128 Thousand EUR | 99.999% |
PHAXIAM Therapeutics S.A. | 671 Thousand EUR | 100.0% |
Financière de Tubize SA | - EUR | -Infinity% |
UCB SA | 1.03 Billion EUR | 100.0% |